Keep up-to-date with our latest projects
We develop, manufacture, and commercialize specialty complex injectable products, generic and 505(b)(2) innovative complex injectable products.
Pipeline
| PRODUCT CANDIDATE | REGULATORY PATHWAY | INDICATION | DEVELOPMENT | CLINICAL STUDY/BE | REGULATORY SUBMISSION | APPROVED |
|---|---|---|---|---|---|---|
| Doxorubicin | ANDA | Ovarian Cancer | ||||
| Amphotericin B | ANDA | Fungi | ||||
| MS01 | ANDA | Acromegaly | ||||
| MS02 | ANDA | Schizophrenia | ||||
| FDL001 | 505(b)(2) | Nausea, Vomiting | ||||
| FDL002 | 505(b)(2) | Fungi | ||||
| FDLC001 | 505(b)(2) | Chronic Pain | ||||
| FDLC002 | 505(b)(2) | Chronic Pain | ||||
| FDM001 | 505(b)(2) | Women's Health | ||||
| FDM002 | 505(b)(2) | Chronic Pain |